CARLOS ALBAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CARLOS ALBAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CARLOS ALBAN. CARLOS ALBAN is EVP, Commercial Operations in AbbVie Inc. ($ABBV).
Latest Insider Trading Transactions of CARLOS ALBAN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 04 2014 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 50.09 | 600 | 30,056 | 205,138 | 205.7 K to 205.1 K (-0.29 %) |
| Mar 04 2014 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 50.09 | 400 | 20,036 | 205,738 | 206.1 K to 205.7 K (-0.19 %) |
| Mar 04 2014 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 50.09 | 282 | 14,125 | 206,138 | 206.4 K to 206.1 K (-0.14 %) |
| Mar 04 2014 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 50.09 | 1,600 | 80,138 | 206,420 | 208 K to 206.4 K (-0.77 %) |
| Mar 04 2014 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 50.91 | 15,319 | 779,890 | 208,020 | 223.3 K to 208 K (-6.86 %) |
| Feb 24 2014 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 51.42 | 81,500 | 4,190,730 | 81,500 | |
| Feb 24 2014 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 47,260 | 0 | 223,339 | 176.1 K to 223.3 K (+26.84 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 28.31 | 34,600 | 979,602 | 0 | |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 26.85 | 21,000 | 563,791 | 0 | |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 28.13 | 17,700 | 497,814 | 0 | |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 28.86 | 33,900 | 978,449 | 0 | |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 27.29 | 35,700 | 974,396 | 0 | |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 45.68 | 27,664 | 1,263,683 | 176,079 | 203.7 K to 176.1 K (-13.58 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 45.68 | 30,550 | 1,395,426 | 203,743 | 234.3 K to 203.7 K (-13.04 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 45.66 | 27,320 | 1,247,562 | 234,293 | 261.6 K to 234.3 K (-10.44 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Sell | S | 45.68 | 28,122 | 1,284,717 | 261,613 | 289.7 K to 261.6 K (-9.71 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 28.31 | 34,600 | 979,602 | 289,735 | 255.1 K to 289.7 K (+13.56 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 26.85 | 21,000 | 563,791 | 255,135 | 234.1 K to 255.1 K (+8.97 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 28.13 | 17,700 | 497,814 | 234,135 | 216.4 K to 234.1 K (+8.18 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 28.86 | 33,900 | 978,449 | 216,435 | 182.5 K to 216.4 K (+18.57 %) |
| May 03 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 27.29 | 35,700 | 974,396 | 182,535 | 146.8 K to 182.5 K (+24.31 %) |
| Mar 04 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 36.73 | 12,960 | 476,021 | 146,835 | 159.8 K to 146.8 K (-8.11 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | A | 35.88 | 115,830 | 4,155,980 | 115,830 | |
| Feb 19 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 37.58 | 9,826 | 369,261 | 159,795 | 169.6 K to 159.8 K (-5.79 %) |
| Feb 19 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Grant | A | 0.00 | 56,700 | 0 | 169,621 | 112.9 K to 169.6 K (+50.21 %) |
| Feb 07 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Option Exercise | M | 33.80 | 2,482 | 83,887 | 0 | |
| Feb 07 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Payment of Exercise | F | 37.28 | 2,325 | 86,676 | 112,921 | 115.2 K to 112.9 K (-2.02 %) |
| Feb 07 2013 | ABBV | AbbVie Inc. | ALBAN CARLOS | EVP, Commercial Ope ... | Buy | M | 33.80 | 2,482 | 83,887 | 115,246 | 112.8 K to 115.2 K (+2.20 %) |
Page: 1